GSK agreed to acquire Nuvalent for $124 per share in a $10.6 billion deal, driving NUVL shares to $105.65 at the open — a 39% premarket surge that held near that level through the first 15 minutes. The S&P 500 opened up 0.63%, the Nasdaq gained 0.69%, and the Russell 2000 added 0